
    
      In this study, eligible subjects will be randomized into study arm or control arm. Treatment
      cycles of chemotherapy will be at most 6 cycles which would be decided by the investigators.
      Progression-free survival (PFS) assessed by the Independent Review Committee (IRC) and
      overall survival (OS) will be the primary outcomes.
    
  